QuarterlyIQ Insights · RMD
News & Events
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
- 2026-04-30Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 30, 2026, ResMed Inc. (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer. Mr. Sandercock will continue to serve as Chief Financial Officer un…
executive changecfo transitionneutralscore 81 - 2026-04-30Item 2.02
and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
earnings preannouncementearnings inlineneutralscore 67 - 2026-04-30Item 8.01
Other Events. On April 30, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.60 per share. The dividend will have a record date of May 14, 2026, payable on June 18, 2026. The dividend will be paid in U.S. currency to holders of Resmed’s common stock trading on the New York Stock Exchange. Holders of CHESS Depositary Interests (“CDIs”) trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the ex…
capital allocationdividend changeneutralscore 52 - 2026-01-29Item 2.02
and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
earnings preannouncementearnings inlineneutralscore 67 - 2026-01-29Item 8.01
Other Events. On January 29, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.60 per share. The dividend will have a record date of February 12, 2026, payable on March 19, 2026. The dividend will be paid in U.S. currency to holders of Resmed’s common stock trading on the New York Stock Exchange. Holders of CHESS Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the e…
capital allocationdividend changeneutralscore 52 - 2025-11-20Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Richard Sulpizio did not seek re-election at the Annual Meeting (as defined below); his term expired on November 19, 2025 at the conclusion of the Annual Meeting, creating a vacancy on our board of directors. On November 19, 2025, our board of directors approved reducing the number of directors serving on our board from twelve (12) to eleven (11).…
executive changeofficer changeneutralscore 57 - 2025-07-31Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On July 28, 2025, Bobby Ghoshal our chief commercial officer, residential care software business (“RCS”) notified us that he intends to resign effective August 1, 2025, to pursue an opportunity as chief operating officer of a software company in a non-competitive industry from ours. SIGNATURES We have authorized the person whose signature appea…
executive changecoo transitionneutralscore 67 - 2021-10-07Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As reported in the Original Filing, on August 24, 2021, we determined that, effective August 25, Rajwant (“Raj”) Sodhi would cease serving as our president – Software-as-a-Service business. He ceased full-time employment with us on September 1, 2021. The termination was without cause. On September 29, 2021, after discussions with Mr. Sodhi, we agre…
executive changepresident transitionneutralscore 57 - 2021-08-27Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 24, 2021, we determined that, effective August 25, Rajwant (“Raj”) Sodhi would cease serving as our president – Software-as-a-Service business and will cease full-time employment with us on September 1, 2021. The termination is without cause, and we are in discussions with Mr. Sodhi regarding a separation package. Effective August 25, 202…
executive changepresident transitionneutralscore 57
General-purpose headline news (a news API), full earnings call transcripts, and macro/sector items flagged when they directly affect this stock are not yet in the marts. Today this tab covers SEC filings surfaced via mart.stock_material_events_history.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.